What is the price-to-earnings ratio of Polynovo?
The price-earnings ratio of Polynovo is currently 15.38.
Polynovo P/S 2024
Polynovo P/S
15.38
Ticker
PNV.AX
ISIN
AU000000PNV0
WKN
A12F4T
As of Dec 20, 2024, Polynovo's P/S ratio stood at 15.38, a 1.38% change from the 15.17 P/S ratio recorded in the previous year.
The Polynovo P/S history
Polynovo Aktienanalyse
What does Polynovo do?
Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Polynovo's P/S Ratio
Polynovo's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Polynovo's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Polynovo's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Polynovo’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Polynovo stock
How has the price-earnings ratio of Polynovo changed compared to last year?
The price-to-earnings ratio of Polynovo has increased by 1.38% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Polynovo high compared to other companies?
Yes, the price-to-earnings ratio of Polynovo is high compared to other companies.
How does an increase in the price-earnings ratio of Polynovo affect the company?
An increase in the price-earnings ratio of Polynovo would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Polynovo affect the company?
A decrease in the price-earnings ratio of Polynovo would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Polynovo?
Some factors that influence the price-earnings ratio of Polynovo are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Polynovo pay?
Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.
What is the dividend yield of Polynovo?
The current dividend yield of Polynovo is .
When does Polynovo pay dividends?
Polynovo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Polynovo?
Polynovo paid dividends every year for the past 0 years.
What is the dividend of Polynovo?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Polynovo located?
Polynovo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Polynovo from 12/20/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.
When did Polynovo pay the last dividend?
The last dividend was paid out on 12/20/2024.
What was the dividend of Polynovo in the year 2023?
In the year 2023, Polynovo distributed 0 AUD as dividends.
In which currency does Polynovo pay out the dividend?
The dividends of Polynovo are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Polynovo
Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
